Kali Stack: Patient Information & Safety Notes
Also known as Kali peptide blend
Other names: kali-peptide-blend
Kali is a proprietary compounded injectable blend combining BPC-157, MOTS-C, 5-Amino-1MQ, and Tesamorelin. Components span FDA-approved (tesamorelin for specific HIV-related indication), investigational (BPC-157, MOTS-C, 5-Amino-1MQ), and unapproved uses. The combination is not FDA-approved.
In plain language
What BPC-157 / MOTS-C / 5-Amino-1MQ / Tesamorelin Blend is used for
- Proprietary research blend with no clinical trials establishing safety or benefit of the combination
Taking this medicine
How it is administered
- Subcutaneous injection
What's in it
Ingredients
Read before you decide
Risks and precautions
Risks and warnings
- Injection site irritation, flushing
- Nausea
- Cumulative risks of component compounds
Who should not take it
- Pregnancy
- History of cancer
Common questions
Patient questions
Is the Kali Stack available to everyone?
No. The Kali Stack is a proprietary compounded formulation available only through specific prescribing and dispensing relationships. It is not FDA-approved. Discuss with a licensed provider.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.